KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $1.0 billion.

  • Teva Pharmaceutical Industries' Prepaid Assets fell 1.06% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 1.06%. This contributed to the annual value of $1.0 billion for FY2024, which is 19.84% down from last year.
  • According to the latest figures from FY2024, Teva Pharmaceutical Industries' Prepaid Assets is $1.0 billion, which was down 19.84% from $1.3 billion recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Prepaid Assets registered a high of $1.3 billion during FY2023, and its lowest value of $945.0 million during FY2020.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Prepaid Assets value was $1.2 billion (recorded in 2022), while the average stood at $1.1 billion.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Prepaid Assets grew by 13.76% in 2021 and then dropped by 19.84% in 2024.
  • Over the past 5 years, Teva Pharmaceutical Industries' Prepaid Assets (Yearly) stood at $945.0 million in 2020, then grew by 13.76% to $1.1 billion in 2021, then increased by 8.09% to $1.2 billion in 2022, then grew by 8.00% to $1.3 billion in 2023, then dropped by 19.84% to $1.0 billion in 2024.